Pangea Bio
Andreas Bender is currently the Chief Informatics and Technology Officer at Pangea Bio, leading the AI platform PangeAI. Andreas is also a Professor for Molecular Informatics at the University of Cambridge and serves as an Advisory Board Member for Cresset software and discovery services and Lhasa Limited. In the past, Andreas was the Chief Scientific Officer at Terra Lumina, Director of Digital Life Sciences at Nuvisan Pharma Services, and held various roles at companies such as AstraZeneca, PharmEnable, and Healx Ltd. Andreas holds a PhD in Cheminformatics from the University of Cambridge.
This person is not in any offices
Pangea Bio
Pangea develops transformative medicines for neurological disorders, deploying AI to uncover promising molecules from natural sources with prior evidence of efficacy and tolerability in humans based on traditional use.